Michael Scott Salka is CEO at AmpliPhi Biosciences Corp (APHB). They have made 1 open-market trade across 1 company since 2015, most recently 2016-12-09.
CIK 0001542981
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $20K since 2015, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| APHB | 11,200 | $50K |
Shares reported on the most recent Form 4, priced at the 2016-12-13 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| APHB | BUY | 2015-10-05 | 2015-10-06 | $4.75 | $20K | -29.1% | +3.0% | +3.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.